Zacks Research Has Bearish Forecast for Clorox Q2 Earnings

The Clorox Company (NYSE:CLX) – Stock analysts at Zacks Research reduced their Q2 2025 earnings estimates for shares of Clorox in a research note issued on Wednesday, November 13th. Zacks Research analyst R. Lohia now expects that the company will earn $1.39 per share for the quarter, down from their prior estimate of $1.56. The consensus estimate for Clorox’s current full-year earnings is $6.85 per share. Zacks Research also issued estimates for Clorox’s Q3 2025 earnings at $1.68 EPS, Q4 2025 earnings at $1.92 EPS, FY2025 earnings at $6.85 EPS, Q2 2026 earnings at $1.69 EPS, Q3 2026 earnings at $1.83 EPS, Q4 2026 earnings at $1.90 EPS, FY2026 earnings at $7.17 EPS, Q1 2027 earnings at $1.81 EPS and FY2027 earnings at $7.56 EPS.

A number of other research analysts also recently commented on CLX. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Finally, BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, Clorox currently has an average rating of “Hold” and an average price target of $155.00.

Clorox Price Performance

Shares of NYSE:CLX opened at $165.74 on Friday. The business has a fifty day simple moving average of $162.38 and a 200-day simple moving average of $147.21. Clorox has a 52 week low of $127.60 and a 52 week high of $169.09. The company has a market cap of $20.52 billion, a P/E ratio of 57.75, a P/E/G ratio of 3.06 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business earned $0.49 earnings per share. Clorox’s revenue was up 27.0% compared to the same quarter last year.

Institutional Investors Weigh In On Clorox

Institutional investors have recently modified their holdings of the business. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter worth about $27,000. First Foundation Advisors bought a new position in Clorox in the 1st quarter worth about $31,000. Innealta Capital LLC acquired a new stake in shares of Clorox in the second quarter valued at approximately $30,000. Trifecta Capital Advisors LLC raised its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.94%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.